China NMPA Product Recall - Hip prosthesis

The National Medical Products Administration (NMPA) issued a recall notice concerning hip prostheses manufactured by Howmedica Osteonics Corp. and distributed by Stryker (Beijing) Medical Devices Co., Ltd. The recall, reported on January 20, 2017, and published on May 22, 2017, addresses a significant product defect: the lack of essential depth markings on specific units of the hip prosthesis, model 0580-1-440, batch number G6106543. This critical issue was identified following customer complaints. Under the NMPA's regulatory framework for medical devices, Howmedica Osteonics Corp. initiated a voluntary recall of the affected product. Crucially, the manufacturer confirmed that none of the recalled products were imported into or sold within the Chinese market. Consequently, for its Chinese operations, the distributor deemed no further specific corrective actions necessary beyond the official reporting to the NMPA. However, provincial and municipal food and drug administrations were advised to enhance their supervision and management of similar medical devices to ensure ongoing public safety.